Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: A critical review and re-analysis of 15 meta-analyses
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Fifteen meta-analyses have been published between 1995 and 2011 to evaluate the efficacy/effectiveness and harms of diverse influenza vaccines--seasonal, H5N1 and 2009 (H1N1)--in various age-classes (healthy children, adults or elderly). These meta-analyses have often adopted different analyses and study selection criteria. Because it is difficult to have a clear picture of vaccine benefits and harms examining single systematic reviews, we compiled the main findings and evaluated which could be the most reasonable explanations for some differences in findings (or their interpretation) across previously published meta-analyses. For each age group, we performed analyses that included all trials that had been included in at least one relevant meta-analysis, also exploring whether effect sizes changed over time. Although we identified several discrepancies among the meta-analyses on seasonal vaccines for children and elderly, overall most seasonal influenza vaccines showed statistically significant efficacy/effectiveness, which was acceptable or high for laboratory-confirmed cases and of modest magnitude for clinically-confirmed cases. The available evidence on parenteral inactivated vaccines for children aged < 2 y remains scarce. Pre-pandemic "avian" H5N1 and pandemic 2009 (H1N1) vaccines can achieve satisfactory immunogenicity, but no meta-analysis has addressed H1N1 vaccination impact on clinical outcomes. Data on harms are overall reassuring, but their value is diminished by inconsistent reporting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantitative Synthesis in Systematic Reviews
Lau, J., Ioannidis, J. P. A., & Schmid, C. H. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-9-199711010-00008 · Cited by 2,517 · cited 1×
“Data were synthesized using the risk ratio metric and using a random effects model.(25) Heterogeneity metrics are also provided (chi-square based Q test and I-squared metric), but should be interpreted cautiously in the presence of few studies per meta-analysis.”
MethodSelf-citationEfficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789 · cited 26×
“858 Human Vaccines & Immunotherapeutics Volume 8 Issue 7 funding source was not reported in one meta-analysis,(14) while all others were funded by not-for-profit institutions.(1,3,9) Two meta-analyses evaluated vaccine efficacy/effectiveness against LCC.”
BackgroundMethodInfluentialUncertainty in heterogeneity estimates in meta-analyses
Ioannidis, J. P. A., Patsopoulos, N. A., & Evangelou, E. (2007) · BMJ · doi:10.1136/bmj.39343.408449.80 · Cited by 1,254 · cited 1×
“Heterogeneity metrics are also provided (chi-square based Q test and I-squared metric), but should be interpreted cautiously in the presence of few studies per meta-analysis.(26) All calculations were made in RevMan 5.”
MethodSelf-citationThe Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature
Gross, P. A., Hermogenes, A. W., Sacks, H. S., Lau, J., & Levandowski, R. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00008 · Cited by 1,100
Evaluation of networks of randomized trials
Salanti, G., Higgins, J. P., Ades, A., & Ioannidis, J. P. (2008) · Statistical Methods in Medical Research · doi:10.1177/0962280207080643 · Cited by 1,078
Self-citationBelshe, R. B., Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382002 · Cited by 916 · cited 1×
“data sets (sample) 25 (18,920) 23 (37,748) γ 11 (35,215) §”
Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025028 · Cited by 752
Ioannidis, J. P. A. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.081086 · Cited by 716
Self-citationNichol, K. L. (1999) · JAMA · doi:10.1001/jama.282.2.137 · Cited by 402
Psychological stress and antibody response to influenza vaccination: A meta-analysis
Pedersen, A. F., Zachariae, R., & Bovbjerg, D. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.01.004 · Cited by 133
Cited by
Immunosenescence: influenza vaccination and the elderly
Haq, K., & McElhaney, J. E. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.03.008 · Cited by 256
“These results correspond to a reduction in influenza-specific hospitalizations by 27–45% [19] as a benefit of global influenza vaccination but more effective vaccines remain an unmet need in the elderly.”
ResultDomnich, A., Arata, L., Amicizia, D., Puig-Barberà, J., Gasparini, R., & Panatto, D. (2017) · Vaccine · doi:10.1016/j.vaccine.2016.12.011 · Cited by 229
Yeh, T.-L., Shih, P.-C., Liu, S.-J., Lin, C.-H., Liu, J.-M., Lei, W.-T., & Lin, C.-Y. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s155110 · Cited by 93
“Currently, the effectiveness of influenza vaccination is not satisfactory and multiple factors contribute to the low effectiveness, including antigen drift, season mismatch, and manufacture technique limitations.(2,38,39) Elderly individuals have both the highest burden of disease and the lowest immune responses to va…”
Metadata
- Authors
- Manzoli, L., Ioannidis, J. P. A., Flacco, M. E., De Vito, C., & Villari, P.
- Venue
- Human Vaccines & Immunotherapeutics
- Publisher
- Informa UK Limited
- Published
- 2012-07
- Volume
- 8
- Issue
- 7
- Pages
- 851-862
- ISSN
- 2164-5515 (ISSN-L)
- 2164-554X
- OpenAlex
- W1984390095
- Cited by
- 97
- References
- 10
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: A critical review and re-analysis of 15 meta-analyses. https://app.cochat.ai/papers/10.4161/hv.19917
- The paper
- Manzoli, L., Ioannidis, J. P. A., Flacco, M. E., De Vito, C., & Villari, P. (2012). Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: A critical review and re-analysis of 15 meta-analyses. Human Vaccines & Immunotherapeutics. https://doi.org/10.4161/hv.19917
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.